[Cephalosporins and enzymuria].
Urinary enzyme excretion was studied in 56 patients treated with cephalosporins in order to evaluate their potential nephrotoxicity. Only in 4 out of 56 patients (7%) was increased NAG, gamma-GT, AlP excretion seen. A rapid return to normal values was observed just after the end of the therapy.
Daghero
O
O
Andreoni
G
G
Arione
R
R
Bendiscioli
L
L
Bramato
C
C
Cimino
T
T
Salassa
B
B
Spezia
C
C
Soranzo
M L
ML
D000118:Acetylglucosaminidase / Q000652:urine; D000293:Adolescent; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000652:urine; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives; D015313:Cefotetan; D015310:Cefotiam; D002440:Cefoxitin / Q000009:adverse effects; D002443:Ceftriaxone / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects*; D002513:Cephamycins / Q000009:adverse effects; D002515:Cephradine / Q000009:adverse effects / Q000031:analogs & derivatives; D002648:Child; D004798:Enzymes / Q000652:urine*; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D005723:gamma-Glutamyltransferase / Q000652:urine
D002511:Cephalosporins; D002513:Cephamycins; D004798:Enzymes; D015313:Cefotetan; D002440:Cefoxitin; D002443:Ceftriaxone; D015310:Cefotiam; C012671:cefroxadine; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D000118:Acetylglucosaminidase; D002515:Cephradine; D002439:Cefotaxime
Cefalosporine ed enzimuria.